This opens a new perspective for understanding the mechanisms of CKD-related CI: in addition to traditional factors such as cerebrovascular disease and anemia, failure of the brain’s clearance system may lead to abnormal accumulation of neurotoxic substances (such as β-amyloid and tau proteins), thereby accelerating neurodegeneration and cognitive decline (40, 41). This evidence concerns the gene MAPT and chronic kidney disease.